{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T22:16:39Z","timestamp":1778969799440,"version":"3.51.4"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2008,6,17]],"date-time":"2008-06-17T00:00:00Z","timestamp":1213660800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Clin Oncol"],"published-print":{"date-parts":[[2008,8]]},"DOI":"10.1038\/ncponc1157","type":"journal-article","created":{"date-parts":[[2008,6,17]],"date-time":"2008-06-17T11:39:22Z","timestamp":1213702762000},"page":"487-491","source":"Crossref","is-referenced-by-count":51,"title":["Audiologic and radiographic response of NF2-related vestibular schwannoma to erlotinib therapy"],"prefix":"10.1038","volume":"5","author":[{"given":"Scott R","family":"Plotkin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marybeth A","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline C","family":"O'Donnell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gordon J","family":"Harris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea I","family":"McClatchey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chris","family":"Halpin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,6,17]]},"reference":[{"key":"BFncponc1157_CR1","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1083\/jcb.200703010","volume":"177","author":"M Curto","year":"2007","unstructured":"Curto M  et al. (2007) Contact-dependent inhibition of EGFR signaling by Nf2\/Merlin. J Cell Biol 177: 893\u2013903","journal-title":"J Cell Biol"},{"key":"BFncponc1157_CR2","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1200\/JCO.2001.19.2.551","volume":"19","author":"AG Sorensen","year":"2001","unstructured":"Sorensen AG  et al. (2001) Comparison of diameter and perimeter methods for tumor volume calculation. J Clin Oncol 19: 551\u2013557","journal-title":"J Clin Oncol"},{"key":"BFncponc1157_CR3","unstructured":"American National Standards Institute (2004) Methods for manual pure-tone threshold audiometry. S3.21 New York: ANSI"},{"key":"BFncponc1157_CR4","first-page":"134","volume-title":"Hearing Measurement: a Book of Readings","author":"A Boothroyd","year":"1981","unstructured":"Boothroyd A and Calkwell S (1981) Vibrotactile thresholds in pure-tone audiometry. In Hearing Measurement: a Book of Readings, edn 2 134\u2013139 (Eds Chaiklin JB.  et al.) New York: Addison Wesley"},{"key":"BFncponc1157_CR5","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/978-0-387-49979-6_11","volume-title":"Evidence-Based Otolaryngology","author":"Christopher F. Halpin","year":"2008","unstructured":"Halpin C: Measuring audiometric outcomes. In Evidence Based Otolaryngology 227\u2013238 (Eds Shin J.  et al.) New York: Springer, in press"},{"key":"BFncponc1157_CR6","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1001\/archotol.1982.00790560016005","volume":"108","author":"E Owens","year":"1982","unstructured":"Owens E  et al. (1982) Interim assessment of candidates for cochlear implants. Arch Otolaryngol 108: 478\u2013483","journal-title":"Arch Otolaryngol"},{"key":"BFncponc1157_CR7","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1097\/00003446-198812000-00006","volume":"9","author":"A Boothroyd","year":"1988","unstructured":"Boothroyd A  et al. (1988) Voice fundamental frequency as an auditory supplement to the speechreading of sentences. Ear Hear 9: 306\u2013312","journal-title":"Ear Hear"},{"key":"BFncponc1157_CR8","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1016\/j.ncl.2007.07.008","volume":"25","author":"CJ Farrell","year":"2007","unstructured":"Farrell CJ and Plotkin SR (2007) Genetic causes of brain tumors: neurofibromatosis, tuberous sclerosis, von Hippel\u2013Lindau, and other syndromes. Neurol Clin 25: 925\u2013946","journal-title":"Neurol Clin"},{"key":"BFncponc1157_CR9","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/00129492-200501000-00016","volume":"26","author":"DG Evans","year":"2005","unstructured":"Evans DG  et al. (2005) Incidence of vestibular schwannoma and neurofibromatosis 2 in the North West of England over a 10 year period: higher incidence than previously thought. Otol Neurotol 26: 93\u201397","journal-title":"Otol Neurotol"},{"key":"BFncponc1157_CR10","doi-asserted-by":"publisher","first-page":"39","DOI":"10.7326\/0003-4819-113-1-39","volume":"113","author":"JJ Mulvihill","year":"1990","unstructured":"Mulvihill JJ  et al. (1990) NIH conference. Neurofibromatosis 1 (Recklinghausen disease) and neurofibromatosis 2 (bilateral acoustic neurofibromatosis). An update. Ann Intern Med 113: 39\u201352","journal-title":"Ann Intern Med"},{"key":"BFncponc1157_CR11","doi-asserted-by":"crossref","unstructured":"National Institutes of Health Consensus Development Conference (1988) Neurofibromatosis. Conference statement. Arch Neurol 45: 575\u2013578","DOI":"10.1001\/archneur.1988.00520290115023"},{"key":"BFncponc1157_CR12","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1212\/01.WNL.0000035638.74084.F4","volume":"59","author":"ME Baser","year":"2002","unstructured":"Baser ME  et al. (2002) Evaluation of clinical diagnostic criteria for neurofibromatosis 2. Neurology 59: 1759\u20131765","journal-title":"Neurology"},{"key":"BFncponc1157_CR13","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1080\/02688690500081206","volume":"19","author":"DG Evans","year":"2005","unstructured":"Evans DG  et al. (2005) Management of the patient and family with neurofibromatosis 2: a consensus conference statement. Br J Neurosurg 19: 5\u201312","journal-title":"Br J Neurosurg"},{"key":"BFncponc1157_CR14","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.3171\/jns.2002.96.6.1063","volume":"96","author":"SR Otto","year":"2002","unstructured":"Otto SR  et al. (2002) Multichannel auditory brainstem implant: update on performance in 61 patients. J Neurosurg 96: 1063\u20131071","journal-title":"J Neurosurg"},{"key":"BFncponc1157_CR15","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1227\/01.NEU.0000255340.26027.53","volume":"60","author":"D Mathieu","year":"2007","unstructured":"Mathieu D  et al. (2007) Stereotactic radiosurgery for vestibular schwannomas in patients with neurofibromatosis type 2: an analysis of tumor control, complications, and hearing preservation rates. Neurosurgery 60: 460\u2013468","journal-title":"Neurosurgery"},{"key":"BFncponc1157_CR16","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1136\/jnnp.74.9.1288","volume":"74","author":"JG Rowe","year":"2003","unstructured":"Rowe JG  et al. (2003) Clinical experience with gamma knife stereotactic radiosurgery in the management of vestibular schwannomas secondary to type 2 neurofibromatosis. J Neurol Neurosurg Psychiatry 74: 1288\u20131293","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"BFncponc1157_CR17","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1136\/jmg.2005.036319","volume":"43","author":"DG Evans","year":"2006","unstructured":"Evans DG  et al. (2006) Malignant transformation and new primary tumours after therapeutic radiation for benign disease: substantial risks in certain tumour prone syndromes. J Med Genet 43: 289\u2013294","journal-title":"J Med Genet"},{"key":"BFncponc1157_CR18","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1056\/NEJMoa050753","volume":"353","author":"FA Shepherd","year":"2005","unstructured":"Shepherd FA  et al. (2005) Erlotinib in previously treated non-small-cell lung cancer. N Engl J Med 353: 123\u2013132","journal-title":"N Engl J Med"}],"container-title":["Nature Clinical Practice Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ncponc1157.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ncponc1157","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ncponc1157.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T20:52:53Z","timestamp":1684443173000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ncponc1157"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,6,17]]},"references-count":18,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2008,8]]}},"alternative-id":["BFncponc1157"],"URL":"https:\/\/doi.org\/10.1038\/ncponc1157","relation":{},"ISSN":["1743-4254","1743-4262"],"issn-type":[{"value":"1743-4254","type":"print"},{"value":"1743-4262","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,6,17]]}}}